Add BrightSurf on Google Email

Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults

A Phase 1 trial of an investigational mRNA COVID-19 vaccine has shown that the vaccine is well-tolerated and generates a strong immune response in older adults, with comparable efficacy to younger age groups. The study enrolled 40 healthy volunteers aged 56-71 years, who received two doses of the vaccine.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalNew England Journal of Medicine·DateSep 30, 2020

Preferences for public allocation of vaccine for COVID-19

A survey study explores public preferences for COVID-19 vaccine allocation. The results show that most people prioritize vaccine distribution to high-risk groups, including seniors and individuals with chronic health conditions. This preference is expected to influence healthcare policy decisions.

SourceJAMA Network·JournalJAMA Network Open·DateSep 29, 2020

Vaccination insights

Researchers investigating BCG vaccination's potential COVID-19 protection find no correlation between infancy vaccination and reduced pandemic cases. Instead, they suggest other factors like public health agency strength or risk aversion may play a role.

SourceUniversity of California - Santa Barbara·JournalClinical Infectious Diseases·DateSep 21, 2020

Belief in conspiracy theories is a barrier to controlling spread of COVID-19

A new study reveals that believing in COVID-19 conspiracy theories predicts increased resistance to vaccination and preventive behaviors, including mask-wearing. The researchers found a widening gap between those who strongly believed in conspiracies and those who did not, with believers being less likely to wear masks and get vaccinated.

American Animal Hospital Association and American Association of Feline Practitioners release new Feline Vaccination Guidelines

The new guidelines update recommendations for feline vaccinations, encouraging veterinarians to consider individualized risk factors and lifestyle-based vaccine calculators. The guidelines aim to improve feline wellbeing by providing tailored vaccination protocols and educating pet owners about the importance of vaccination.

SourceSAGE·JournalJournal of Feline Medicine and Surgery·DateSep 1, 2020

Vaccine developed for human herpesvirus 6B (HHV-6B)

A new vaccine candidate has been developed for HHV-6B, a virus that causes exanthem subitum in infants. The vaccine targets the gH/gL/gQ1/gQ2 complex and induces strong immunity against the virus. Animal experiments have shown that the vaccine prevents HHV-6B infection and activates dendritic cells to induce innate immunity.

SourceKobe University·JournalPLOS Pathogens·DateAug 20, 2020

Vaccines through microneedle skin patches

Researchers are developing and testing technology for delivering vaccine doses via the skin using microneedles. This innovative approach aims to improve patient compliance and yield better health outcomes, with potential benefits including reduced burden on healthcare systems and increased accessibility for self-administration at home.

HPV vaccination linked to lower risk of precancerous condition

A study published in Acta Obstetricia et Gynecologica Scandinavica found that HPV vaccination significantly reduces the risk of high-grade cervical intraepithelial neoplasia, a precancerous condition leading to cervical cancer. Vaccination coverage was high among young women born in 1993, resulting in a 30% lower risk compared to those...

SourceWiley·JournalActa Obstetricia Et Gynecologica Scandinavica·DateAug 5, 2020

Iron deficiency during infancy reduces vaccine efficacy

Clinical studies in Kenya suggest that iron deficiency during infancy may reduce the protection provided by vaccinations. In one study, researchers found that anaemic infants had more than twice the risk of lacking protective antibodies against diphtheria and other pathogens.

SourceETH Zurich·JournalFrontiers in Immunology·DateJul 28, 2020

SMART finds new and safe method that enhances dengue vaccination -- Paving way to wide use

A team of researchers from SMART has developed a novel approach to induce strong and broad immunity against the dengue virus. Sequential immunization was found to be more effective in inducing higher levels of neutralizing antibodies to all four DENV serotypes than traditional tetravalent-formulated immunization.

Comprehensive study of vaccine safety concludes that vaccines are 'remarkably safe'

A comprehensive review of vaccine data over 20 years found vaccines to be remarkably safe, with most safety issues identified through existing postmarketing surveillance programs. The study confirms the effectiveness of the vaccine approval system and postmarketing surveillance in ensuring public health benefits while minimizing risks.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateJul 27, 2020